"Elon Musk's brain chip". U.S. approves human clinical trials
Neuralink, the neurotechnology startup co-founded by Elon Musk, announced Thursday that it has received approval from the US Food and Drug Administration (FDA) to conduct the first clinical trial in humans, on its Twitter account.
"This is the result of the great work done by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people," the company said in a tweet.
"Recruitment is not yet open in our clinical trial. We will be announcing more information on this matter soon."
CNBC reported on Thursday that Neuralink plans to place coin-sized implants in human brains, called Link, with the aim of allowing the human brain to control complex electronic devices using only nerve signals, which will help people with complete paralysis regain contact with their loved ones by moving these nerve signals and writing with their minds.